Can a lactating woman safely use GLP1 receptor agonists (e.g., exenatide, liraglutide, dulaglutide, semaglutide) while breastfeeding?
Each BPC-157 dose exerts its effects briefly before being eliminated, reducing the potential for sustained pathway activation that might be more concerning
A reduction in TIMP-1 activity may result in uncontrolled MMP activity, thereby exacerbating membrane degradation in the context of premature rupture of the membrane (73)
Xie C et al (2021) Role of bile acids in the regulation of food intake, and their dysregulation in metabolic disease
Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar. Journal of the American College of Cardiology, vol
Two categories of GLP-1 agonist drugs are available - Human GLP-1 backbone agents and Exendin-4 backbone agents